3 views on Virtus

Livewire Exclusive

Livewire Markets

3 views on Virtus. After a strong IPO in 2013 the Virtus Health share price has had challenging period post their interim result. Morgans Life Sciences analyst Scott Power sees recent share price weakness as a buying opportunity, suggesting the market is overplaying perceived growth headwinds. Power says, we see further upside from a move into an overseas region which would likely re-invigorate interest in this name. This view is echoed by Don Williams, CIO of Platypus. We believe the market has forgotten about some of the growth options for Virtus. We think it is likely that they will acquire something overseas and that the local growth prospects are good enough to justify the valuation. Power currently has a price target of $8.94 for Virtus (currently trading at $7.50). Livewire spoke with Virtus CEO, Ms Susan Channon a few weeks ago. Watch the video here:


Livewire Exclusive
Livewire Markets

Livewire Exclusive brings you exclusive content from a wide range of leading fund managers and investment professionals.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.


Sign In or Join Free to comment